Five months after recovering from a bone marrow transplant, Robin Roberts returned to Good Morning America (GMA)! The morning-show co-host has overcome breast cancer, and most recently a condition known as myelodysplastic syndrome (MDS). Few probably had ever heard of this condition, much less know what it is. MDS is a disorder where the bone marrow produces too few functioning red blood cells, white blood cells and platelets. Robin's treatment involved chemotherapy, a stem cell transplant and a long recovery.
Sources: abc2news.com, About.com, Memorial Sloan-Kettering Cancer Center
Subscribe to:
Post Comments
(
Atom
)
This is a great story which can truly highlight the importance of ongoing clinical research. There are many Americans who do not have any real knowledge of clinical trials, and there are many more that simply get the wrong impression from them. I think that in light of those recent sequestrations that have placed new limits on the NIH and others, this could really show more people why that could be a really bad thing.
ReplyDeleteThe sequestration has had a significant impact on many programs. For me, I have been most disheartened by the cuts that were made to ongoing cancer research projects. It sad to think that we may not be able to advance cancer treatments due to these budget cuts.
DeleteThank you for your response Stephen! PMG is dedicated to sharing clinical trial information in an effort to educate the public about the benefits of participation in research studies. It's important for people to know that clinical trials can be a treatment option worth considering...and their contribution to medical advancement can make a difference in the healthcare advancements of tomorrow.
ReplyDelete